Source:http://linkedlifedata.com/resource/pubmed/id/12799619
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2003-7-23
|
pubmed:abstractText |
Human prefrontal cortical neurons express catechol O-methyltransferase (COMT), an enzyme that inactivates the neurotransmitter dopamine. A functional polymorphism of COMT, Val(108/158) Met, affects prefrontal function, and the high-activity Val allele has been reported to be a genetic risk factor for schizophrenia. We used in situ hybridization histochemistry to measure mRNA levels of COMT in the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia (N=14) and of normal controls (N=15). While the groups did not differ in terms of mean level of COMT mRNA, there was a significantly different laminar pattern of COMT mRNA expression in pyramidal neurons (F=2.68, df=4,108, P <0.04); patients with schizophrenia had relatively lower levels in the superficial (II/III) layers and higher levels in the intermediate/deep (IV/V) layers (P&<0.01), while in controls, the expression was homogeneous across layers. Neither the mean level nor the laminar distribution of COMT mRNA was related to the Val(108/158) Met genotype, suggesting that the feedback regulation of mRNA level is not a compensation for the functional effect of the COMT polymorphism. The disease-related laminar difference of COMT expression may be involved in dysregulation of dopamine signaling circuits in the DLPFC of patients with schizophrenia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0893-133X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1521-30
|
pubmed:dateRevised |
2011-5-18
|
pubmed:meshHeading |
pubmed-meshheading:12799619-Adult,
pubmed-meshheading:12799619-Aged,
pubmed-meshheading:12799619-Aged, 80 and over,
pubmed-meshheading:12799619-Analysis of Variance,
pubmed-meshheading:12799619-Catechol O-Methyltransferase,
pubmed-meshheading:12799619-Female,
pubmed-meshheading:12799619-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:12799619-Genotype,
pubmed-meshheading:12799619-Humans,
pubmed-meshheading:12799619-Male,
pubmed-meshheading:12799619-Middle Aged,
pubmed-meshheading:12799619-Prefrontal Cortex,
pubmed-meshheading:12799619-RNA, Messenger,
pubmed-meshheading:12799619-Schizophrenia
|
pubmed:year |
2003
|
pubmed:articleTitle |
Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia.
|
pubmed:affiliation |
Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA. matsum_m@yamanouchi.co.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study
|